The use of replication-deficient Ad vectors to express ING4 gene demonstrated improved therapeutic efficacy and growth suppression of lung, pancreatic, and breast carcinoma tumor xenografts [34–36]. The gene discussed is ING4; the disease is breast carcinoma.